- Report
- June 2025
- 400 Pages
Global
From €4507EUR$4,949USD£3,886GBP
- Report
- January 2025
- 210 Pages
Global
From €4548EUR$4,995USD£3,923GBP
- Report
- April 2026
- 282 Pages
Canada
From €4416EUR$4,850USD£3,809GBP
- Report
- April 2026
- 168 Pages
India
From €4416EUR$4,850USD£3,809GBP
- Report
- April 2026
- 327 Pages
China
From €4416EUR$4,850USD£3,809GBP
- Report
- April 2026
- 372 Pages
Germany
From €4416EUR$4,850USD£3,809GBP
- Report
- May 2025
- 150 Pages
Global
From €4416EUR$4,850USD£3,809GBP
- Report
- July 2024
- 154 Pages
Global
From €3870EUR$4,250USD£3,338GBP
- Report
- May 2025
- 93 Pages
Global
From €3500EUR$4,117USD£3,124GBP
- Report
- January 2024
- 20 Pages
United States
From €997EUR$1,095USD£860GBP
- Report
- May 2021
- 50 Pages
China
From €2368EUR$2,600USD£2,042GBP
- Report
- October 2024
- 74 Pages
Global
From €3500EUR$4,117USD£3,124GBP
The Sedation market within the context of Anesthetic Drugs is a subset of the larger anesthetic drug market. It is composed of drugs used to induce a state of sedation, which is a state of reduced consciousness and decreased responsiveness to external stimuli. Sedation is used in a variety of medical procedures, such as endoscopies, colonoscopies, and other minor surgeries. It is also used in intensive care units to reduce the stress of critically ill patients.
The sedation market is composed of a variety of drugs, including benzodiazepines, barbiturates, and propofol. These drugs are used to induce a state of sedation, as well as to reduce anxiety and pain. The sedation market is highly competitive, with a number of companies offering a variety of drugs.
Some of the companies in the sedation market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. These companies offer a variety of sedation drugs, including benzodiazepines, barbiturates, and propofol. Show Less Read more
